Pathstone Holdings, LLC Athira Pharma, Inc. Call Options Transaction History
Pathstone Holdings, LLC
- $25.3 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATHA
# of Institutions
51Shares Held
16.8MCall Options Held
24.1KPut Options Held
0-
Perceptive Advisors LLC New York, NY5.4MShares$21.9 Million0.07% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.23MShares$13.1 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$6.23 Million0.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$6.05 Million0.55% of portfolio
-
Black Rock Inc. New York, NY676KShares$2.74 Million0.0% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $153M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...